Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Romani

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2009
Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectivesPasquale Niscola, Laura Scaramucci, Marco Giovannini, et al.
BMJ Supportive & Palliative Care|July 19, 2020
Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burdenKathrin Sommer, Marco Vignetti, Francesco Cottone, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Expert Review of Anticancer Therapy|March 23, 2011
Management of hematological malignancies in patients affected by renal failurePasquale Niscola, Gisella Vischini, Andrea Tendas, et al.
Herpes : the Journal of the IHMF|October 18, 2007
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measuresPasquale Niscola, Alessio Pio Perrotti, Giovanni del Poeta, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
Haematologica|June 12, 2013
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy programTamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.
Haematologica|November 8, 2011
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual diseaseFrancesco Mannelli, Giacomo Gianfaldoni, Tamara Intermesoli, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2009
Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectivesPasquale Niscola, Laura Scaramucci, Marco Giovannini, et al.
BMJ Supportive & Palliative Care|July 19, 2020
Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burdenKathrin Sommer, Marco Vignetti, Francesco Cottone, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Expert Review of Anticancer Therapy|March 23, 2011
Management of hematological malignancies in patients affected by renal failurePasquale Niscola, Gisella Vischini, Andrea Tendas, et al.
Herpes : the Journal of the IHMF|October 18, 2007
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measuresPasquale Niscola, Alessio Pio Perrotti, Giovanni del Poeta, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
Haematologica|June 12, 2013
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy programTamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.
Haematologica|November 8, 2011
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual diseaseFrancesco Mannelli, Giacomo Gianfaldoni, Tamara Intermesoli, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Pageof 3